| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |